Article ; Online: Pandemic COVID-19: Current status and challenges of antiviral therapies.
2020 Volume 7, Issue 4, Page(s) 502–519
Abstract: The pandemic COVID-19, caused by a new coronavirus SARS-CoV-2 infection, has infected over 12 million individuals and caused more than 55,200 death worldwide. Currently, there is no specific drug to treating this disease. Here we summarized the ... ...
| Abstract | The pandemic COVID-19, caused by a new coronavirus SARS-CoV-2 infection, has infected over 12 million individuals and caused more than 55,200 death worldwide. Currently, there is no specific drug to treating this disease. Here we summarized the mechanisms of antiviral therapies and the clinic findings from different countries. Antiviral chemotherapies have been conducted by in multiple cohorts in different counties. Although FDA has fast approved remdesivir for treating COVID-19, it only speeds up recovery from COVID-19 with mildly reduced mortality. The chloroquine was suggested a potential drug against SARS-CoV-2 infection due to its |
|---|---|
| Keywords | covid19 |
| Language | English |
| Publishing date | 2020-07-07 |
| Publishing country | Netherlands |
| Document type | Journal Article |
| ZDB-ID | 2821806-1 |
| ISSN | 2352-3042 ; 2352-3042 |
| ISSN (online) | 2352-3042 |
| ISSN | 2352-3042 |
| DOI | 10.1016/j.gendis.2020.07.001 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.